The Society for In Vitro Biology is excited to announce that Dr. Thomas Hartung, MD, PhD will give the Keynote address at the 2022 In Vitro Biology meeting in San Diego, CA (June 4-7, 2022). Dr. Hartung is the Director of the Center for Alternatives to Animal Testing (CAAT) and the inaugural Doerenkamp-Zbinden Endowed Chair in evidence-based Toxicology in the Department of Environmental Sciences at the Johns Hopkins Bloomberg School of Public Health, where he has been on the faculty since 2009. Dr. Hartung also served as the CEO of the Steinbeis Technology Transfer Center for Alternative Methods (ECVAM) at the European Commission Joint Research Center in Italy and was integral in accelerating the alternative methods validation process and establishing a network of more that 400 experts from all stakeholder groups to facilitate global regulatory harmonization in toxicity testing. In 2009, he was named the 2nd most cited German pharmacologist by Labjournal.  He received the Agilent Thought Leader Award in 2009 for his research into the use of toxicity pathways to predict developmental neurotoxicity.

Please join us for Dr. Hartung’s Keynote address during the Opening Ceremony of the 2022 In Vitro Biology Meeting on June 5th at the Town & Country in San Diego, California.

To view the current 2022 Program, please visit our meeting website.

Submitted by the Editorial Staff

Share this page